Breaking News Instant updates and real-time market news.

FOLD

Amicus

$14.56

0.37 (2.61%)

07:08
08/07/18
08/07
07:08
08/07/18
07:08

Amicus raises FY18 Galafold revenue guidance $80M-$90M from $75M-$85M

Revenue consensus $85.21M. For FY18 the company is increasing its total Galafold revenue guidance to $80M to $90M from the previous range of $75M to $85M. This reflects global revenue from all expected 2018 commercial markets. Based on the increase in expected 2018 revenue and operating expenses that are trending favorably to budget, the Company is updating its full-year 2018 net cash spend to $220M to $250M from the previous range of $230M to $260M. The current cash position, including proceeds from the February 2018 equity offering and expected Galafold revenues, is sufficient to fund ongoing Fabry and Pompe program operations into at least 2021. Potential future business development collaborations, pipeline expansion, and investment in biologics manufacturing capabilities could impact the Company's future capital requirements.

  • 07

    Aug

  • 13

    Aug

  • 12

    Sep

FOLD Amicus
$14.56

0.37 (2.61%)

09/15/17
JPMS
09/15/17
NO CHANGE
Target $15
JPMS
Overweight
JPMorgan continues to see upside in Amicus shares
JPMorgan analyst Anupam Rama says Amicus Therapeutics remains one of his top picks, and that he continues to see upside from current share levels, ahead of the upcoming Pompe data readout. The analyst sees a high probability that the Q3 data update will meet or exceed the efficacy benchmarks, leading to increased probability of success/revenue estimates across Street models. His base case, with a 75% probability of success assumption, still provides for 10%-15% upside from current share levels. His "homerun scenario," which is maintaining the 6MWD benefit shown in Q2 or better, has the stock rallying 35%-40%.
10/04/17
BOFA
10/04/17
NO CHANGE
Target $20
BOFA
Buy
Amicus price target raised to $20 from $15 at BofA/Merrill
BofA/Merrill analyst Tazeen Ahmad raised Amicus' price target to $20 from $15 saying the Phase 1/2 trial results of ATB200/AT2221 in Pompe disease were impressive. The analyst thinks the strong data justifies progression into pivotal trials and may result in an accelerated approval path. Ahmad rates Amicus a Buy.
04/11/18
JPMS
04/11/18
NO CHANGE
JPMS
Overweight
Amicus risk/reward favorable into regulatory update, says JPMorgan
JPMorgan analyst Anupam Rama notes that a regulatory update for Amicus Therapeutics' Pompe program is expected in Q2. The analyst continues to like the reward/risk profile of the shares going into the update. An accelerated approval path forward is "very much on the table," based on the strength of the Phase 1/2 data, Rama tells investors in a research note. He sees "more win scenarios than lose." The analyst believes Amicus shares can rally 30%-50% should an accelerated approval path forward emerge. Rama keeps an Overweight rating on Amicus with a $19 price target.
05/08/18
JPMS
05/08/18
NO CHANGE
JPMS
Amicus lower on Pompe program commentary, says JPMorgan
JPMorgan analyst Anupam Rama attributes today's post-earnings weakness in shares of Amicus Therapeutics to "conservative commentary" on the call related to the Pompe program. The analyst, however, does not believe that the regulatory scenarios he outlined last month for the program have fundamentally changed. Nonetheless, Rama thinks commentary on the call, particularly on timing, was perceived as cautious. Amicus shares are down 7.5% to $13.49 in midday trading.

TODAY'S FREE FLY STORIES

IBTX

Independent Bank

$55.08

-1.08 (-1.92%)

17:05
07/22/19
07/22
17:05
07/22/19
17:05
Earnings
Independent Bank reports Q2 adjusted EPS $1.22, consensus $1.27 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 26

    Aug

  • 23

    Sep

RNST

Renasant

$34.10

-0.49 (-1.42%)

17:04
07/22/19
07/22
17:04
07/22/19
17:04
Earnings
Renasant reports Q2 EPS 80c with items, consensus 81c »

Reports Q2 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

17:03
07/22/19
07/22
17:03
07/22/19
17:03
Hot Stocks
Steel Dynamics announces planned new flat roll steel mill site selection »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Brown & Brown reports Q2 organic revenue up 3.9% »

Reports Q2 EBITDA margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAE

Haemonetics

$122.44

0.35 (0.29%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Haemonetics updates financial reporting segments »

Haemonetics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 05

    Sep

  • 09

    Sep

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:01
07/22/19
07/22
17:01
07/22/19
17:01
Earnings
Brown & Brown reports Q2 adjusted EPS 32c, consensus 28c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DLX

Deluxe

$41.95

0.41 (0.99%)

17:00
07/22/19
07/22
17:00
07/22/19
17:00
Hot Stocks
Deluxe names Chris Thomas chief revenue officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 19

    Sep

GE

General Electric

$10.22

0.18 (1.79%)

, AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

16:57
07/22/19
07/22
16:57
07/22/19
16:57
Hot Stocks
Avalon GloboCare and GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

GE

General Electric

$10.22

0.18 (1.79%)

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:55
07/22/19
07/22
16:55
07/22/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Viveve 

Viveve trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFF

Village Farms

$10.69

0.48 (4.70%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Initiation
Village Farms initiated  »

Village Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$75.72

0.995 (1.33%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Hot Stocks
Best Buy beneficial owner Richard Schulze sells $32.4M in company shares »

Best Buy beneficial owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ORGO

Organogenesis

$5.85

-0.27 (-4.41%)

16:50
07/22/19
07/22
16:50
07/22/19
16:50
Syndicate
Organogenesis commences exchange offer »

Organogenesis Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

WD

Walker & Dunlop

$55.46

-0.39 (-0.70%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Hot Stocks
Walker & Dunlop appoints Chief Production Officer to Lead FHA finance team »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 15

    Aug

EQBK

Equity Bancshares

$24.43

-0.19 (-0.77%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Earnings
Equity Bancshares reports Q2 EPS 58c, consensus 60c »

The net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

RPAY

Repay Holdings

$11.51

-0.26 (-2.21%)

16:47
07/22/19
07/22
16:47
07/22/19
16:47
Hot Stocks
Monroe Capital reports 6.5% passive stake in Repay Holdings »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

TRWH

Twin River Worldwide

$28.10

0.1 (0.36%)

16:45
07/22/19
07/22
16:45
07/22/19
16:45
Hot Stocks
Twin River Worldwide extends tender offer expiration time to July 26 »

Twin River Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRWH

Twin River Worldwide

$28.10

0.1 (0.36%)

16:44
07/22/19
07/22
16:44
07/22/19
16:44
Earnings
Twin River Worldwide reports preliminary Q2 revenue $146.5M-$148.5M »

Consensus $161.33M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$137.84

0.55 (0.40%)

, MU

Micron

$47.21

1.7 (3.74%)

16:43
07/22/19
07/22
16:43
07/22/19
16:43
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks rose as earnings…

EFX

Equifax

$137.84

0.55 (0.40%)

MU

Micron

$47.21

1.7 (3.74%)

MTN

Vail Resorts

$235.48

9.665 (4.28%)

SKIS

Peak Resorts

$10.85

5.71 (111.09%)

FB

Facebook

$202.32

3.94 (1.99%)

INTC

Intel

$51.36

1.1 (2.19%)

AVGO

Broadcom

$296.11

6.06 (2.09%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

BX

Blackstone

$47.81

2.18 (4.78%)

CQP

Cheniere Energy Partners

$43.96

0.835 (1.94%)

BYND

Beyond Meat

$193.91

17.26 (9.77%)

HAL

Halliburton

$23.76

2.02 (9.29%)

PAYS

Paysign

$13.68

-3.81 (-21.78%)

CADE

Cadence Bancorp

$15.86

-3.75 (-19.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 12

    Aug

  • 26

    Aug

  • 27

    Aug

  • 23

    Sep

  • 26

    Sep

  • 27

    Oct

  • 13

    Nov

ACAD

Acadia

$25.97

0.28 (1.09%)

16:36
07/22/19
07/22
16:36
07/22/19
16:36
Hot Stocks
Breaking Hot Stocks news story on Acadia »

Acadia down over 16% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

ACAD

Acadia

$25.97

0.28 (1.09%)

16:35
07/22/19
07/22
16:35
07/22/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Acadia 

Acadia trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

FULC

Fulcrum Therapeutics

$12.84

0.35 (2.80%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Hot Stocks
Fulcrum Therapeutics chairman Mark Levin buys $1.3M in company shares »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$105.66

-1.35 (-1.26%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Earnings
Celanese still sees 'path to' FY19 EPS of $10.50, consensus $10.20 »

CEO Lori Ryerkerk says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FTI

TechnipFMC

$25.61

0.5 (1.99%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
TechnipFMC awarded iEPCI contract from Neptune Energy for Seagull project »

TechnipFMC has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

CE

Celanese

$105.66

-1.35 (-1.26%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
Celanese reports Q2 operating EBITDA $458M vs. $573M last year »

Reports Q2 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CTST

CannTrust

$2.73

-0.04 (-1.44%)

16:32
07/22/19
07/22
16:32
07/22/19
16:32
Hot Stocks
CannTrust agrees to waive exclusivity provision under agreement with Kindred »

CannTrust Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.